logo-loader
viewWillow Biosciences Inc.

Willow Bioscience takes first major step towards development of pharmaceutical grade CBG

Willow Bioscience (TSE: WLLW: OTCQX: CANSF) CEO Trevor Peters joined Steve Darling from Proactive Vancouver with news the company has hit a major milestone in their development. Peters talks about this significant step. Peters also talked about the company as a whole and what separates them from others in their sector.

Quick facts: Willow Biosciences Inc.

Price: 0.79 CAD

TSX:WLLW
Market: TSX
Market Cap: $62.32 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Willow Biosciences Inc. named herein, including the promotion by the Company of Willow Biosciences Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Auryn Resources spins our Peruvian assets creating a new company called Fury...

Auryn Resources (TSE: AUG- NYSEAMERICAN: AUG) Executive Chairman Ivan Bebek and new company Fury Gold Mines CEO Mike Timmins joined Steve Darling from Proactive Vancouver with news Auryn is creating a new gold-focused exploration and development company called Fury Gold Mines. Bebek discusses...

13 hours, 10 minutes ago

2 min read